中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 金属研究所
  3. 中国科学院金属研究所
Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions

文献类型：期刊论文

作者Zeng, Guoming1,7; Jin, Libo4,5,6; Ying, Qinsi3; Chen, Haojie6; Thembinkosi, Murinda Charmaine6; Yang, Chunguang2; Zhao, Jinlong2; Ji, Hao6; Lin, Sue6; Peng, Renyi6
刊名CANCER MANAGEMENT AND RESEARCH
出版日期2020
卷号12页码:10411-10421
关键词cancer immunotherapy Treg cells FoxP3 targeting Treg cells anti-cancer
ISSN号1179-1322
DOI10.2147/CMAR.S265828
通讯作者Zhang, Maolan(zml@cqu.edu.cn) ; Sun, Da(sunday@wzu.edu.cn)
英文摘要Cancer immunotherapy is a promising approach that has recently gained its importance in treating cancer. Despite various approaches of immunotherapies being used to target cancer cells, they are either not effective against all types of cancer or for all patients. Although efforts are being made to improve the cancer immunotherapy in all possible ways, one important hindrance that lowers the immune response to kill cancer cells is the infiltration of Regulatory T (Treg) cells into the tumor cells, favoring tumor progression, on one hand, and inhibiting the activation of T cells to respond to cancer cells, on the other hand. Therefore, new anti-cancer drugs and vaccines fail to show promising results against cancer. This is due to the infiltration of Treg cells into the tumor region and suppression of anti-cancer activity. Thus, regardless of various types of immunotherapies being practiced, understanding the mechanisms of how Treg cells favor tumor progression and inhibition of anti-cancer activity is worthwhile. Therefore, the review highlights the importance of Tregs cells and how depletion of Treg cells can pave the way to an effective immunotherapy by activating the immune responses against cancer.
资助项目Natural Science Foundation of Zhejiang Province[Q19E010021] ; Natural Science Foundation of Zhejiang Province[LQ20C020003] ; Natural Science Foundation of Zhejiang Province[LQ20C200015] ; National Natural Science Foundation of China[51901160] ; National Natural Science Foundation of China[51808086] ; Shenzhen Science and Technology Research Funding[JCYJ20160608153641020] ; Special project of basic research and frontier exploration in Chongqing[cstc2018jcyjAX0078]
WOS研究方向Oncology
语种英语
WOS记录号WOS:000579720000004
出版者DOVE MEDICAL PRESS LTD
资助机构Natural Science Foundation of Zhejiang Province ; National Natural Science Foundation of China ; Shenzhen Science and Technology Research Funding ; Special project of basic research and frontier exploration in Chongqing
源URL[http://ir.imr.ac.cn/handle/321006/140959]  
专题金属研究所_中国科学院金属研究所
通讯作者Zhang, Maolan; Sun, Da
作者单位1.Chongqing Univ Sci & Technol, Chongqing 401331, Peoples R China
2.Chinese Acad Sci, Inst Met Res, Shenyang 110016, Liaoning, Peoples R China
3.Univ Chinese Acad Sci, Wenzhou Inst, Wenzhou 325035, Zhejiang, Peoples R China
4.Biomed Collaborat Innovat Ctr Wenzhou, Engn Lab Zhejiang Prov Pharmaceut Dev Growth Fact, Wenzhou 325035, Zhejiang, Peoples R China
5.Biomed Collaborat Innovat Ctr Zhejiang Prov, Wenzhou 325035, Zhejiang, Peoples R China
6.Wenzhou Univ, Inst Life Sci, Higher Educ Pk, Wenzhou 325035, Zhejiang, Peoples R China
7.China Met Construct Engn Grp Co Ltd, Chongqing 400044, Peoples R China
推荐引用方式
GB/T 7714		 Zeng, Guoming,Jin, Libo,Ying, Qinsi,et al. Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions[J]. CANCER MANAGEMENT AND RESEARCH,2020,12:10411-10421.
APA Zeng, Guoming.,Jin, Libo.,Ying, Qinsi.,Chen, Haojie.,Thembinkosi, Murinda Charmaine.,...&Sun, Da.(2020).Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions.CANCER MANAGEMENT AND RESEARCH,12,10411-10421.
MLA Zeng, Guoming,et al."Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions".CANCER MANAGEMENT AND RESEARCH 12(2020):10411-10421.

入库方式： OAI收割

来源：金属研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。